Panacea Acquisition Corp. II
| General Information | |
| Business: | (Note: This is a blank-check company or SPAC offering of Class A ordinary shares. This is NOT a unit offering (stock and warrants) that is typical of SPAC IPOs.) We intend to capitalize on our management team’s background and experience to identify innovative companies in the biotechnology sector that are domiciled in North America or Europe. (Note: Panacea Acquisition Corp. II priced its SPAC IPO on April 6, 2021, according to the terms in its prospectus: 15 million Class A ordinary shares at $10 each to raise $150 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2021 |
| Contact Information | |
| Address | 357 Tehama Street Floor 3 San Francisco, CA 94103 |
| Phone Number | (415) 966-0807 |
| Web Address | |
| View Prospectus: | Panacea Acquisition Corp. II |
| Financial Information | |
| Market Cap | $205.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | PANA |
| Exchange | NASDAQ |
| Shares (millions): | 15.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $150.0 mil |
| Manager / Joint Managers | Cowen and Company |
| CO-Managers | - |
| Expected To Trade: | 4/7/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |